Silver Book Fact

An Alzheimer’s disease research study showed that billions of dollars could be saved if physicians could intervene before someone becomes symptomatic. This positive net savings occurred with both drug treatment and caregiver-support programs; the greatest benefits with a combination of both.

Weimer, David L, and Mark A Sager. Early Identification and Treatment of Alzheimer’s Disease: Social and fiscal outcomes. Alzheimers Dement. 2009; 5(3): 215-26. http://www.alzheimersanddementia.com/article/S1552-5260(09)00029-6/abstract

Reference

Title
Early Identification and Treatment of Alzheimer’s Disease: Social and fiscal outcomes
Publication
Alzheimers Dement
Publication Date
2009
Authors
Weimer, David L, and Mark A Sager
Volume & Issue
Volume 5, Issue 3
Pages
215-26
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • A study of Parkinson’s disease treatments found that pramipexole is a cost-effective treatment for early and advanced Parkinson’s disease. The total cost-effectiveness ratio was $8,837/QALY for patients with early Parkinson’s…  
  • Medicare Costs, Slowed Progression  
  • 32 drugs are currently in development for Parkinson’s disease.  
  • A treatment breakthrough that slowed the progression of Alzheimer’s disease would reduce the number of people with the disease from 2.4 million to 1.1 million in 2020, and from 6.5…  
  • Stopping the Progress of Parkinson’s Would Save >$440,000 per Person